CRYM CryoMass Technologies Inc (QB)

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K 

 

CURRENT REPORT 

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

 

Date of Report (Date of earliest event reported) August 31, 2023

 

Cryomass Technologies Inc 
(Exact name of registrant as specified in its charter) 

 

Nevada		000-56155		82-5051728
(State or other jurisdiction of		(Commission File Number)		(IRS Employer
incorporation)				Identification No.)

 

1001 Bannock St Suite 612, Denver CO		80204
(Address of principal executive offices)		(Zip Code)

  

Registrant’s telephone number, including area code 303-416-7208

 

(Andina Gold Corp.) 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class		Trading Symbol		Name of each Exchange on which Registered
None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b -2 of this chapter). 

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On August 31, 2023 CryoMass Technologies Inc (‘Company”) issued a press release (“Press Release”), which was also disseminated on the same day via email to certain shareholders who provided contact information. A copy of the Press Release is furnished as Exhibit 99.1.

 

The information in Item 7.01 of this Current Report and Exhibit 99.1 is being furnished, not filed, pursuant to Items 7.01 and 9.01 of Form 8-K. Accordingly, the information in Items 7.01 and 9.01 of this Current Report, including Exhibit 99.1, will not be subject to liability under Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), and will not be incorporated by reference into any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, or the Exchange Act, unless specifically identified therein as being incorporated by reference. The furnishing of information in this Current Report, including Exhibit 99.1, is not intended to, and does not, constitute a determination or admission by the Company that the information in this Current Report, including Exhibit 99.1, is material or complete, or that investors should consider this information before making an investment decision with respect to any security of the Company or any of its affiliates.

 

Item 9.01. Financial Statements and Exhibits.

 

EXHIBIT 99.1		Press Release August 31, 2023 CryoMass Technologies Inc
EXHIBIT 104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

NOTE REGARDING FORWARD LOOKING STATEMENTS

 

Any statements in this Current Report on Form 8-K or any exhibit hereto about future expectations, plans, and prospects for the Company, including statements about Company’s future expectations, beliefs, goals, plans, or prospects, constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. In some cases you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “likely,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will,” “would,” or similar expressions and the negatives of those terms.

 

These forward-looking statements involve risks, uncertainties, and assumptions that could cause actual performance or results to differ materially from those expressed or suggested by the forward-looking statements. If any of these risks or uncertainties materialize, or if any of Company’s assumptions prove incorrect, its actual results could differ materially from the results expressed or implied by these forward-looking statements. These risks and uncertainties include risks associated with: Company’s ability to achieve or maintain profitability, and to effectively manage its anticipated growth; and the risks described in the other filings Company makes with the Securities and Exchange Commission from time to time, including the risks described under the heading “Risk Factors” in Company’s Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent quarterly reports on Form 10-Q, and which should be read in conjunction with its financial results and forward-looking statements. All forward-looking statements in this Current Report on Form 8-K or any exhibit hereto are based on information available to Company as of the date hereof, and it does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 

Cryomass Technologies Inc

 

/s/ Christian Noël
Christian Noël
CEO
Date: August 31, 2023

 

 

2

 

Exhibit 99.1

 

CryoMass Partners with California Manufacturer to Revolutionize Cannabinoid Production

 

August 31, 2023 07:10 ET| Source: Cryomass Technologies

 

DENVER, Aug. 31, 2023 (GLOBE NEWSWIRE) -- CryoMass Technologies Inc. (the “Company” or ” innovative cryogenic botanical refinement systems, has signed a license agreement with a California c RubberRock Inc. (“RubberRock”) co-owned by famed extractor Brad Robertson, co-founder of Guild Led by Chief Science Officer Brad Robertson and co-founder Kevin Ahaesy, RubberRock aims to beco wholesale of cannabis ingredients.

 

After demonstrating the trichome separation capabilities of the CryoSift Separator™, CryoMass most i efficient and scalable way to utilize CryoSift™ for large scale cannabinoid production. This meant findi expertise open to new methods beyond existing extraction processes. Current extraction techniques u concentrated input material like CryoSift™.

 

CryoMass found an ideal partner in pioneer extractor Brad Robertson. In 2015, Robertson and Guild E commercialize high-purity THCa crystalline, the natural form of THC found in raw cannabis plants. Rob extracting and isolating cannabinoids and terpenes using proprietary methods. His ability to produce p solvent, and in higher yields than other processors put him in a class of his own.

 

 

 

 

THCa crystalline

 

 

Robertson stated the collaboration “will allow RubberRock to become a top cannabinoid supplier in Ca CryoMass’s game-changing refinement process.”

 

Commercialization Update

 

With strong demand and solid pipeline, CryoMass continues selectively vetting partners to deploy its te upholding standards for controlled growth. The company has fielded over 200 inquiries from 20+ count prospects and is actively involved in conversations with 25+ of them. Near-term plans target two additi regions.

 

“We want to thank our 4000+ loyal shareholders for their continued support as we work to deliver on th said Noël.

 

 

 

CryoSift Separator Beta Unit™

 

The common stock of CryoMass Technologies Inc. trades on the OTC QB market under the symbol C contact the Company by email at investors@cryomass.com or by telephone at 303-222-8092.

 

About CryoMass

 

 

Forward-looking Statements

 

This press release may contain forward-looking statements within the meaning of the United States Pr 1995 that involve known and unknown risks, uncertainties and other factors, including risk factors iden which may cause the actual results, performance or achievements of the Company to be materially dif performance or achievements expressed or implied by the forward-looking statements. Risks and unc changes in the regulatory environment affecting the sale and use of cannabis or hemp products and of the Company will consider entering at a given time, demand for the Company’s products, internal fund Company, product roll-out, competition, our dependence upon our commercial partners, variations in t commercial matters involving the Company, its products and the markets in which the Company opera economic conditions. The forward-looking statements in this press release are made only as of the dat by applicable securities laws, the Company disclaims any intention or obligation to update or revise an a result of new information, future events or otherwise.

 

Caution Regarding Cannabis Operations in the United States

 

Investors should note that there are significant legal restrictions and regulations that govern the canna Marijuana, as defined in the U.S. Controlled Substances Act, remains a Schedule I drug under the res law in the U.S. to, among other things, cultivate, distribute or possess cannabis. Financial transactions intended to promote, cannabis-related business activities in the U.S. may form the basis for prosecutio laundering legislation. Please carefully review the Company’s SEC filings with respect to related risk fa

 

Photos accompanying this announcement are available at

 

https://www.globenewswire.com/NewsRoom/AttachmentNg/49bca5db-16c6-4bc6-8e87-1e3648020a7

 

https://www.globenewswire.com/NewsRoom/AttachmentNg/17de15d6-9871-4c15-a0ef-31ee2670df72

 

 

4

 

v3.23.2

Cover	Aug. 31, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Aug. 31, 2023
Entity File Number	000-56155
Entity Registrant Name	Cryomass Technologies Inc
Entity Central Index Key	0001533030
Entity Tax Identification Number	82-5051728
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	1001 Bannock St Suite 612
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80204
City Area Code	303
Local Phone Number	416-7208
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false

---